NCT07725796
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07725796
Title A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.